Bristol-Myers Squibb
BMY
#189
Rank
HK$826.45 B
Marketcap
HK$405.97
Share price
0.38%
Change (1 day)
-7.48%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.12. In 2024 the company made an earnings per share (EPS) of -HK$34.41 a decrease over its 2023 EPS that were of HK$30.20.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-167.29%
2024-HK$34.41-213.92%
2023HK$30.2030.2%
2022HK$23.20-6.04%
2021HK$24.69-179.29%
2020-HK$31.14-281.37%
2019HK$17.17-27.21%
2018HK$23.59
2016HK$20.79175.26%
2015HK$7.55-19.83%
2014HK$9.42-22.44%
2013HK$12.1434.48%
2012HK$9.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.39-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.12 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.73 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.30 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$28.85 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
HK$23.63 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$81.27 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.52-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.43 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.55 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA